Search Results

Advanced data analysis for GPCR pharmacology Dr. Understanding the pharmacology data analysis framework we use for GPCRs. Module 2 - Quantifying agonist pharmacology and biased agonism. Module 3 - Antagonist pharmacology and binding assay analysis. Samuel Hoare Sam Hoare is a pharmacology data analyst with 30 years experience in GPCR pharmacology.

Applying Pharmacology to Drug Discovery Dr. Pharmacology is a unique discipline and is critical to drug discovery. What makes each drug type unique to therapeutic pharmacology? 3. Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta,

< GPCR News < GPCRs in Oncology and Immunology Biochemical pharmacology of adenylyl cyclases in cancer Published date October 1, 2024 Abstract "Globally, despite extensive research and pharmacological advancement

Committee Sponsors GPCR Retreat Program < Back to schedule Complex Allosteric Cannabinoid Receptor Pharmacology Robert and his lab have been interested in the molecular pharmacology of cannabinoids for nearly 10 years

Principles of Pharmacology in Drug Discovery I Dr. In general, registrants will receive a comprehensive understanding of the unique science of pharmacology Registrants will learn: Essentials of measuring pharmacologic activity of ligands (affinity, efficacy Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

Graciela Pineyro is a professor of pharmacology at the department of pharmacology and physiology of the She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain.

Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological

He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class Today, Sam is a pharmacology data analyst and the founder of Pharmechanics LLC , a consultancy and data in vitro pharmacology data to advance drug discovery. Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences Sam is known for demystifying complicated and newly-emerging pharmacology concepts, enabling them to

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable

obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry received his Ph.D. in Pharmacology Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr. Terry Kenakin on the web LinkedIn UNC Department of Pharmacology Amazon ResearchGate Pubmed . Dr.

Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council He is a 2021 Clarivate Analytics Highly Cited Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification, and a member of the Faculty of 1000 (Molecular Pharmacology division) and an elected Fellow of the British Pharmacological Society (BPS).

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Mark Connor Undergraduate BSc with Honours in Pharmacology from University of Sydney (1987, snake neurotoxins ), Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology Currently pursuing molecular pharmacology of phytocannabinoids and novel synthetic cannabinoids, with

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

Principles of Pharmacology in Drug Discovery II Dr. Modules Lecture 1: The Eyes to See- The Importance of Pharmacologic Assays. Terry Kenakin After obtaining a BS in chemistry and PhD in Pharmacology at the University of Alberta, then moved to the University of North Carolina School of Medicine where currently I am a Professor of Pharmacology My interests are in receptor theory, pharmacology applied to drug discovery and allosteric protein function

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology

more than 25 years of experience in drug development. have been engaged in GPCR cellular and clinical pharmacology I have participated and initiated methodologies for development of pharmacologically active anti-GPCR have published or contributed in 38 published scientific work mainly in the field of immunology and pharmacology

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

Pharmacy from Minia University in 2011 and began my career as a teaching and research assistant in Pharmacology Later, I completed my Master's degree in Pharmacology at Minia University, focusing on hydrogen sulfide's as a visiting graduate student, and in September 2022, I enrolled in the direct-entry Physiology and Pharmacology I employ a multidisciplinary approach that combines molecular pharmacology, biochemical assays, and biophysical GPCR Title: Antibodies Expand the Scope of Angiotensin Receptor Pharmacology About Meredith Skiba "Meredith

Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the She received a Ph.D. in Medical Pharmacology from The University of Arizona in 2015 and completed a postdoctoral Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab research awards, including the William James Psychology Award, the Hank Yamamura Endowed Fellowship in Pharmacology She is currently a faculty trainer for the University of Minnesota's MS and Ph.D. programs in Pharmacology

Arthur Christopoulos " Arthur Christopoulos is the Professor of Analytical Pharmacology and the Dean Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Black Analytical Pharmacology Lecturer; the GSK Award for Research Excellence and a Doctor of Laws ( Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology &

out his Ph.D. at King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological as Chief Scientific Officer, a contract research organization specializing in molecular and cellular pharmacology several pre-clinical drug discovery projects for both GPCR and non-GPCR targets, using its expertise in pharmacology

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics Maddi is currently a second year Ph.D. student in the Molecular Pharmacology and Therapeutics (MPaT)